B
y 2030, the demand for primary hip arthroplasty is estimated to increase by 174%, to 572,000 annually in the U.S. 1 . Presently, the need for adequate postoperative pain control continues to be an issue 2, 3 . Pain control and comfort level are linked to earlier mobilization, better range of motion, decreased length of hospital stay, and lower medical cost [4] [5] [6] . Consequently, much interest in an effective analgesic regimen while minimizing side effects has been generated. Patient-controlled epidural analgesia (PCEA) has been used as an effective form of postoperative analgesia but can be associated with urinary retention, hypotension, pruritus, and motor block [7] [8] [9] . It may also lead to a delay in hospital discharge due to nausea and vomiting. This has led to other modes of pain management, such as the use of periarticular injection (PAI) of local anesthetic, morphine, corticosteroids, and, at times, nonsteroidal anti-inflammatory drugs (NSAIDs) along with a multimodal pain regimen [10] [11] [12] . The goal is to target different pain pathways in a synergistic fashion by using specific agents with analgesic and/or anti-inflammatory properties. A preemptive approach is also achieved by giving medications preoperatively.
In view of the controversy associated with the use of PCEA and the potential advantage of PAI in reducing side effects, we undertook this double-blind, placebo-controlled study comparing the two techniques. We hypothesized that PAI would lead to faster recovery with earlier hospital discharge, lower pain scores, and decreased opioid utilization.
Materials and Methods
A fter institutional review board approval and informed consent were obtained, ninety patients were enrolled in this double-blind, placebo-controlled study (from February 2012 to January 2013) at a university-affiliated orthopaedic teaching hospital. The study was registered with ClinicalTrials.gov, identifier NCT01658072. Patients were consecutively randomized (1:1 allocation, parallel trial design) to either the PAI or the PCEA group. The group to which patients were assigned was indicated in numbered sealed envelopes, Osteonecrosis of head and neck of femur 1 0 
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T 20, 2015 which were prepared by an independent researcher and opened by the anesthesiologist assigned to the procedure after enrollment. Patients who were fifty to eighty years old were eligible if they had a diagnosis of osteoarthritis and were scheduled for primary unilateral total hip replacement. Surgery was performed by one of five surgeons using a standard posterolateral approach and without the use of cement. Exclusion criteria included an allergy or intolerance to one of the study medications, an American Society of Anesthesiologists (ASA) physical status classification score of IV 13 , hepatic or renal failure, and chronic opioid use (more than three months) (Fig. 1 ).
The characteristics of the patients in the two groups were similar (Table I ). All patients received dexamethasone (6 mg, orally) thirty to sixty minutes before transfer to the operating room as part of our standard antiemetic regimen. In addition, the PAI group received sustained-release oxycodone (10 mg) and a clonidine patch (100 mg/24 hr). The PCEA group received a placebo sustainedrelease oxycodone pill and a placebo clonidine patch. Every patient also had combined spinal-epidural anesthesia with 0.5% bupivacaine (10 mg, 12.5 mg, or 15 mg). Both groups received intraoperative intravenous sedation with midazolam and propofol and 15 mg of ketorolac intravenously.
At the end of surgery, a surgeon who had received video training performed the local infiltration in the PAI group; this consisted of a deep injection into the anterior and posterior capsule, the periosteum, the gluteus maximus, and the abductor muscles and fascia lata. The deep injection consisted of 0.5% bupivacaine with epinephrine, 30 mL; morphine, 1 mL of 8 mg/mL; methylprednisolone, 1 mL of 40 mg/mL; and cefazolin, 500 mg in 10 mL in normal saline solution, 42 mL. Epinephrine was used to prolong the action of the local anesthetic by decreasing the reabsorption rate. In addition, 40 mL of 0.25% bupivacaine was injected into subcutaneous tissue prior to wound closure.
On arrival in the postanesthesia care unit, both groups received urinary catheters, which were subsequently removed at the same time as the epidural catheters. Postoperative epidural with patient-controlled infusion pump (0.06% bupivacaine and hydromorphone, 10 mg/mL) was started at 2 mL/hr with a 4 mL bolus with 10-min lockout and with a 20 mL hourly maximum in the PCEA group. Using a pump with the same settings, the PAI group received epidural infusion with normal saline solution. The basal rate was reduced to 0 mL/hr at 6:59 A.M. on the first postoperative day, and the epidural catheter was removed at noon. In addition to an epidural for patient-controlled anesthesia, both the PAI and the PCEA groups received acetaminophen, 1000 mg every eight hours; ketorolac, 30 mg (15 mg if sixty-five years of age or older) every six hours intravenously until postoperative day 1, for a total of four doses; oxycodone every three hours as needed (5 mg for mild pain; 10 mg for moderate to severe pain); and meloxicam once the ketorolac was discontinued. The PAI group also received sustained-release oxycodone, 10 mg every twelve hours for forty-eight hours, for a total of four doses; the PCEA group had the placebo.
Assessments were made using various questionnaires including patient satisfaction, Quality of Recovery (QoR)-40 14 , and Opioid-Related Symptom Distress Scale (ORSDS) 15, 16 on postoperative days 1, 2, and 3 as well as at three months. During the first three postoperative days, patients were interviewed twice daily by a research assistant to assess readiness for discharge (the primary outcome), pain, activity, and analgesic use. Patients rated their preoperative pain at 
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rest and with movement on a numeric rating scale (NRS), with 0 representing no pain and 10, the worst pain imaginable. They were contacted by telephone at three months to identify neuropathic pain (using the Leeds Assessment of Neuropathic Symptoms and Signs [LANSS], which was also administered before surgery 17 ). Discharge readiness was calculated from the time of leaving the operating room to the time the discharge criteria were met.
Patients were judged ready to be discharged when (1) the patient-controlled infusion pump (if present) was discontinued (the epidural catheter was removed at noon on postoperative day 1); (2) they were experiencing only mild pain (an NRS score of <4); (3) they had required no parenteral narcotics within the last four hours; (4) they had minimal nausea within the last four hours; and (5) they were eating normally. They were also required to have no urinary catheter, a dry surgical wound, no acute medical problems, and stable vital signs during physical therapy as well as the ability to transfer independently to and from a chair as well as from the bed to a standing position. Additional criteria for readiness for discharge included the ability to walk 12.2 m (40 ft) with only a walker or crutch, if needed.
Study data were collected and managed using REDCap (Research Electronic Data Capture) electronic data capture tools 18 . REDCap is a secure, web-based application designed to support data capture for research studies, providing an intuitive interface for validated data entry, audit trails for tracking data manipulation and export procedures, automated export procedures for seamless data downloads to common statistical packages, and procedures for importing data from external sources.
Statistical Methods
The primary outcome was readiness for discharge. We hypothesized that the periarticular injection would reduce the time until patients were ready for discharge by 0.5 day. We considered a reduction of 0.5 day to be the minimal clinically important difference on the basis of preliminary data indicating a mean time to readiness for discharge after total hip replacement (and standard deviation [SD]) of 3.5 ± 1.2 days. A power analysis with two-sided hypothesis testing and a = 0.05 indicated that forty-five patients in each group were needed in order to identify the minimal clinically important difference of 0.5 day with 80% power. Continuous variables are presented as the mean (and standard deviation) and compared using a two-sample t test or Mann-Whitney-Wilcoxon rank test. Discrete variables are presented using proportions and were analyzed with a chi-square test or Fisher exact test. Cox proportional-hazards regression was performed to compare readiness for discharge while adjusting for patient demographics (sex, body mass index [BMI] , age, race, and ASA classification). Linear regression analysis was conducted to compare length of stay while adjusting for the same set of patient demographics. NRS pain scores were analyzed using generalized estimating equations (GEEs), a technique that is better suited for repeated measurements of pain scores from a group of individuals 19 . Significance was set at a p value of <0.05. 
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Results
F
orty-one patients in the PAI group and forty-three patients in the PCEA group received the allocated intervention. Both groups had similar demographic characteristics (Table I) . The time to readiness for discharge and length of stay were the same in both groups (Figs. 2 and 3) . The mean length of stay was 3.0 ± 0.8 days for the PAI group compared with 3.1 ± 0.7 days for the PCEA group (p = 0.46). Thirty-three patients in the PAI group were discharged to home and eight, to a rehabilitation center; thirty-one patients in the PCEA group were discharged to home and twelve, to a rehabilitation center. The mean time to readiness for discharge was 2.4 ± 0.7 days for the PAI group compared with 2.3 ± 0.8 days for the PCEA group (hazard ratio [HR], 1.05; 95% confidence interval [CI], 0.63 to 1.74; p = 0.86) ( Table II) . The difference in pain at rest between groups was significant only on postoperative day 1 (P.M., p = 0.03). An overall mean difference of 0.74 for pain with ambulation (95% CI, 0.18 to 1.31; p = 0.01) and 0.80 for pain during physical therapy (95% CI, 0.09 to 1.51; p = 0.03) favored the PCEA group (Table III) . GEE analysis of pain scores over time included age, race, BMI, ASA classification, and sex. Females experienced higher pain at rest (p = 0.03) and with ambulation (p = 0.01). Overweight/ obese patients had lower pain scores at rest (p = 0.04) and with ambulation (p = 0.04).
The mean total opioid (epidural and oral) consumption (converted to oral morphine equivalents in milligrams [20] [21] [22] ) was significantly higher in the PAI group on postoperative day 0 (43 ± 21 compared with 28 ± 23; p = 0.002), on postoperative day 1 (57 ± 26 compared with 29 ± 39; p = 0.0002), and for postoperative days 0 through 2 (136 ± 59 compared with 90 ± 79; p = 0.004) (Table IV) . Oral opioid consumption was higher in the PAI group on postoperative days 0 and 1 (p < 0.0001). One patient from the control group (PAI) converted to intravenous patient-controlled analgesia because of severity of pain. However, the composite ORSDS scores were significantly higher in the PCEA group in terms of severity and bothersomeness (p < 0.05) ( Table V) . The notable symptoms included nausea (p = 0.01), vomiting (p = 0.04), and itchiness (p = 0.01). There was a higher prevalence of headache in the PCEA group. That group also had a higher likelihood of dizziness (p = 0.05). QoR-40 and LANSS scores, along with patient satisfaction, were similar between the groups (Tables  V and VI) .
Discussion
I n this study comparing PCEA with PAI among patients undergoing total hip arthroplasty, we found no difference between groups in time to readiness for discharge or length of stay. Readiness for discharge was used as the main outcome because it accounts for many aspects of recovery, including level of pain, nausea, medical status, and rehabilitation milestones. Length of stay may depend on additional factors, such as the availability of a bed at a rehabilitation center, and some patients may be discharged to that center without meeting the milestones. There was no major difference between the PAI group and the PCEA group in terms of the number of patients who went home versus to a rehabilitation center. In addition, in actual practice, patients receiving PAI with a multimodal pain regimen do not have an epidural catheter or a urinary catheter inserted. Whether the presence of these two interventions could have contributed to our results is unknown. However, this was a requirement given the double-blind, placebo-controlled design of the study. Of note, the epidural catheter was removed by noon on postoperative day 1, and the likelihood of it having affected the time to discharge is low.
Few total hip arthroplasty studies have compared PCEA with PAI. Andersen et al. found a shorter length of stay with PAI (a mixture of ropivacaine, ketorolac, and epinephrine) compared with PCEA, but the analgesic regimen was different between the two groups (the use of ketorolac was not uniform) 23 . Pandazi et al. studied sixty-eight total hip arthroplasty patients divided among three groups 24 . One group had intravenous patient-controlled analgesia and was compared with a group who had PAI (ropivacaine, morphine, cefuroxime, epinephrine, methylprednisolone, and clonidine) and with a group using PCEA. Morphine consumption and pain scores were lower in the PAI group, but there was no difference between the PAI and epidural groups. Of note, our study is, to our knowledge, the first double-blind, placebocontrolled study in total hip arthroplasty surgery looking at the use of PCEA and PAI. Two double-blind, randomized trials in total hip arthroplasty have assessed the use of PAI with ropivacaine with or without additives compared with normal saline solution; decreased narcotic use, along with less pain, was found in one, but the other did not show any difference in opioid consumption, pain scores, or length of stay 25, 26 . In the former, the analgesic regimen was not equivalent in both groups, while in the latter, the same multimodal regimen was used.
Another double-blind, randomized study looking at PAI compared levobupivacaine with normal saline solution and found similar pain-intensity scores but with less morphine consumption for the first twelve hours in the levobupivacaine group 27 . In a randomized clinical trial of ninety-six patients that compared the use of levobupivacaine and epinephrine with the use of no injection, no difference in morphine consumption, rehabilitation milestones, or earlier mobilization was found 28 . Busch et al. randomized sixty-four patients to receive either a periarticular injection of ropivacaine, epinephrine, and morphine or no injection, with all patients receiving patient-controlled analgesia 29 . The PAI group used less patient-controlled analgesia at six hours postoperatively and at twenty-four hours after surgery. The PAI group also had lower pain scores on activity in the postanesthesia care unit. However, there was no effect on patient satisfaction or length of stay. Two other randomized studies using either preemptive analgesia and/or a multimodal pain regimen found different results. Lee et al. compared the use of regional anesthesia and PAI (morphine, methylprednisolone, and ropivacaine) with the use of general anesthesia and patient-controlled analgesia and found reduced pain scores in the PAI group but without any difference in length of hospital stay 30 . Utilizing a comparative cohort design, Parvataneni et al. found lower pain scores and length of stay (3.2 compared with 4.2 days) in the group who received PAI compared with the group who received intravenous patientcontrolled analgesia 12 . A meta-analysis by Kehlet and Andersen concluded that the previously published studies assessing the use of PAI in hip replacement surgery lacked proper design and did not support the use of PAI 31 . Hence, we undertook this double-blind, 20, 2015 placebo-controlled study comparing the use of a multimodal analgesic regimen consisting of sustained-release oxycodone, a clonidine patch, and PAI with the use of an epidural analgesic regimen of bupivacaine and hydromorphone, both protocols currently used at our institution. Both groups, in addition, received acetaminophen, NSAIDs, and oxycodone as needed. It is possible that different results may be obtained with different versions of either the PCEA or PAI protocols. Although the primary outcome was similar in both groups, overall, better analgesia was achieved in the PCEA group both with ambulation and with physical therapy (ambulation, p = 0.01; and physical therapy, p = 0.03). Interestingly, women had higher pain scores both at rest and with ambulation. From previous studies, females tend to report higher pain scores [32] [33] [34] . Patients with a BMI of ‡30 kg/m 2 had less pain, although in another study of patients who underwent hip arthroplasty, obesity was not a factor in pain experienced postoperatively 35 . There was higher analgesic consumption in the PAI group; however, the ORSDS scores were greater in the PCEA group, with nausea, vomiting, dizziness, and pruritus being the most common symptoms. This was an interesting finding because neuraxial opioids may protect against nausea and vomiting 36, 37 . A systematic review by Choi et al. found no difference between epidural and systemic analgesia in the frequency of nausea and vomiting 8 . Of note, the PAI group received 40 mg of methylprednisolone as part of the intervention. This may serve as a depot of corticosteroids. The use of corticosteroids has been proven as an effective method of decreasing emesis 38, 39 . Similar QoR-40 and LANSS scores were found in both groups. Patient satisfaction was also similar.
In conclusion, both types of analgesic regimens were associated with similar functional recovery scores and patient satisfaction. PAI did not decrease the time to discharge; it was associated with higher pain scores and greater opioid consumption but lower ORSDS scores and, hence, fewer side effects. The decision to choose one regimen over the other should not be made on the basis of readiness for discharge, but mostly on patient characteristics and preference. In the narcotic-naive or nauseaprone patient, PAI may be preferable; however, in the patient with chronic pain, PCEA may be more effective. n
